Our investigations confirmed that Tf-LP-ERN nanoparticles effectively targeted tumor tissues and exhibited increased anti-liver cancer efficacy, as they enabled ERN to strongly affect immunoregulatory pathways in liver cancer cells and in a xenografted tumor mouse model. This evidence concerns the gene TF and neoplasm.